Skip to main content
TipRanks
Go Ultimate75% OFF

Arecor Therapeutics PLC (AREC) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

Arecor Therapeutics PLC has a market cap or net worth of GBX 35.11M. The enterprise value is GBX 20.50M.

Market Cap
GBX 35.11M
Enterprise Value
GBX 20.50M

Share Statistics

Arecor Therapeutics PLC has 45,300,716 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
45,300,716
Owned by Insiders
4.35%
Owned by Institutions
―

Financial Efficiency

Arecor Therapeutics PLC’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -66.42%.

Return on Equity (ROE)
0.10
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
-66.42%
Return on Capital Employed (ROCE)
-0.72
Revenue Per Employee
51.94K
Profits Per Employee
20.12K
Employee Count
33
Asset Turnover
0.21
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Arecor Therapeutics PLC is 155.00. Arecor Therapeutics PLC’s PEG ratio is -3.79.

PE Ratio
155.00
PS Ratio
-369.56
PB Ratio
7.94
Price to FCF
-7.84
Price to Operating Cash Flow
-6.57
PEG Ratio
-3.79

Income Statement

In the last 12 months, Arecor Therapeutics PLC had revenue of 1.71M and earned 664.00K in profits. Earnings per share was 0.02.

Revenue
1.71M
Gross Profit
1.05M
Operating Income
-4.67M
Pretax Income
994.00K
Net Income
664.00K
EBITDA
-4.45M
Earnings Per Share (EPS)
0.02

Cash Flow

In the last 12 months, operating cash flow was -4.45M and capital expenditures -26,000, giving a free cash flow of -4.48M billion.

Operating Cash Flow
-4.45M
Free Cash Flow
-4.48M
Free Cash Flow per Share
-0.12

Dividends & Yields

Arecor Therapeutics PLC pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-12.75%
Earnings Yield
0.65%

Stock Price Statistics

Beta
0.69
52-Week Price Change
4.73%
50-Day Moving Average
80.26
200-Day Moving Average
69.89
Relative Strength Index (RSI)
37.90
Average Volume (3m)
27.49K

Important Dates

Arecor Therapeutics PLC upcoming earnings date is Apr 27, 2027, TBA (Not Confirmed).

Last Earnings Date
Sep 30, 2026
Next Earnings Date
Apr 27, 2027
Ex-Dividend Date
―

Financial Position

Arecor Therapeutics PLC as a current ratio of 4.35, with Debt / Equity ratio of 1.52%

Current Ratio
4.35
Quick Ratio
4.35
Debt to Market Cap
0.00
Net Debt to EBITDA
0.65
Interest Coverage Ratio
-424.18

Taxes

In the past 12 months, Arecor Therapeutics PLC has paid 62.00K in taxes.

Income Tax
62.00K
Effective Tax Rate
0.06

Enterprise Valuation

Arecor Therapeutics PLC EV to EBITDA ratio is -6.47, with an EV/FCF ratio of -7.49.

EV to Sales
-352.94
EV to EBITDA
-6.47
EV to Free Cash Flow
-7.49
EV to Operating Cash Flow
-7.53

Balance Sheet

Arecor Therapeutics PLC has GBX 3.15M in cash and marketable securities with GBX 57.00K in debt, giving a net cash position of GBX 3.10M billion.

Cash & Marketable Securities
GBX 3.15M
Total Debt
GBX 57.00K
Net Cash
GBX 3.10M
Net Cash Per Share
GBX 0.07
Tangible Book Value Per Share
GBX 0.10

Margins

Gross margin is -800.00%, with operating margin of 5113.68%, and net profit margin of -200.00%.

Gross Margin
-800.00%
Operating Margin
5113.68%
Pretax Margin
-472.63%
Net Profit Margin
-200.00%
EBITDA Margin
5455.79%
EBIT Margin
5670.53%

Scores

Smart Score
6
AI Score
47